Hydrochlorothiazide NDC 0228-2820

NDC codes

FDA NDC Directory

Product NDC (as listed)0228-2820Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00228-2820Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0228-2820-11	00228282011	100 TABLET in 1 BOTTLE (0228-2820-11)Marketed from Mar 12, 2007
0228-2820-96	00228282096	1000 TABLET in 1 BOTTLE (0228-2820-96)Marketed from Dec 1, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrochlorothiazide
Generic name (nonproprietary): hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Actavis Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040707
Marketing start: Mar 12, 2007
Marketing end: Jun 30, 2027
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 0228-2820_2b5bc2c3-8d3c-43c8-8e4c-e44aca5624cdSPL ID 2b5bc2c3-8d3c-43c8-8e4c-e44aca5624cdSPL set ID afdf1170-25a0-496d-b293-36ee0db2cd1eRxCUI 429503UNII 0J48LPH2THUPC 0302282820117
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400228282011 followed by a unit qualifier and the quantity

Package 00228-2820-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 1, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Use in Pregnancy Routine use of diuretics during normal pregnancy is inappropriate and exposes mother and…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040707

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040707
Product	Strength	Form · route	Labeler	Product NDC
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-3443
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	A-S Medication Solutions	50090-6931